Literature DB >> 18258754

Interactions of GABA A receptor activation and light on period mRNA expression in the suprachiasmatic nucleus.

J Christopher Ehlen1, Colleen M Novak, Mary C Karom, Karen L Gamble, H Elliott Albers.   

Abstract

Activation of gamma-aminobutyric acid (GABA) A receptors in the suprachiasmatic nucleus (SCN) resets the circadian clock during the day and inhibits the ability of light to reset the clock at night. Light in turn acts during the day to inhibit the phase-resetting effects of GABA. Some evidence suggests that Period mRNA changes in the SCN are responsible for these interactions between light and GABA. Here, the hypothesis that light and the GABA A receptor interact by altering the expression of Period 1 and/or Period 2 mRNA in the SCN is tested. The GABA A agonist muscimol was injected near the SCN just prior to a light pulse, during the mid-subjective day and the early and late subjective night. Changes in Period 1 and Period 2 mRNA were measured in the SCN by in situ hybridization. Light-induced Period 1 mRNA was inhibited by GABA A receptor activation in the early and late subjective night, while Period 2 mRNA was only inhibited during the late night. During the subjective day, light had no effect on the ability of muscimol to suppress Period 1 mRNA hybridization signal. Thus, light and GABA A receptor activation inhibit each other's ability to induce behavioral phase shifts throughout the subjective day and night. However, only in the late night are these behavioral effects correlated with changes in Period gene expression. Together, our data support the hypothesis that the interacting effects of light and GABA are the result of the opposing actions of these stimuli on Period mRNA, but only during the subjective night.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258754     DOI: 10.1177/0748730407310785

Source DB:  PubMed          Journal:  J Biol Rhythms        ISSN: 0748-7304            Impact factor:   3.182


  10 in total

Review 1.  Physiological responses of the circadian clock to acute light exposure at night.

Authors:  Michael C Antle; Victoria M Smith; Roxanne Sterniczuk; Glenn R Yamakawa; Brooke D Rakai
Journal:  Rev Endocr Metab Disord       Date:  2009-12       Impact factor: 6.514

Review 2.  Collective timekeeping among cells of the master circadian clock.

Authors:  Jennifer A Evans
Journal:  J Endocrinol       Date:  2016-05-06       Impact factor: 4.286

3.  Sustained activation of GABAA receptors in the suprachiasmatic nucleus mediates light-induced phase delays of the circadian clock: a novel function of ionotropic receptors.

Authors:  Daniel L Hummer; J Christopher Ehlen; Tony E Larkin; John K McNeill; John R Pamplin; Colton A Walker; Phillip V Walker; Daryl R Dhanraj; H Elliott Albers
Journal:  Eur J Neurosci       Date:  2015-05-12       Impact factor: 3.386

4.  A multiscale model to investigate circadian rhythmicity of pacemaker neurons in the suprachiasmatic nucleus.

Authors:  Christina Vasalou; Michael A Henson
Journal:  PLoS Comput Biol       Date:  2010-03-12       Impact factor: 4.475

5.  Ethanol modulates mammalian circadian clock phase resetting through extrasynaptic GABA receptor activation.

Authors:  B McElroy; A Zakaria; J D Glass; R A Prosser
Journal:  Neuroscience       Date:  2009-08-18       Impact factor: 3.590

6.  The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion Injury.

Authors:  Yoshimasa Oyama; Colleen Marie Bartman; Jennifer Gile; Daniel Sehrt; Tobias Eckle
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

Review 7.  The dynamics of GABA signaling: Revelations from the circadian pacemaker in the suprachiasmatic nucleus.

Authors:  H Elliott Albers; James C Walton; Karen L Gamble; John K McNeill; Daniel L Hummer
Journal:  Front Neuroendocrinol       Date:  2016-11-25       Impact factor: 8.606

8.  Direct and specific effect of sevoflurane anesthesia on rat Per2 expression in the suprachiasmatic nucleus.

Authors:  Megumi Anzai; Norio Iijima; Shimpei Higo; Ken Takumi; Izumi Matsuo; Keisuke Mori; Yumiko Ohe; Kana Kadota; Toshio Akimoto; Atsuhiro Sakamoto; Hitoshi Ozawa
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

9.  Epigenetic suppression of mouse Per2 expression in the suprachiasmatic nucleus by the inhalational anesthetic, sevoflurane.

Authors:  Keisuke Mori; Norio Iijima; Shimpei Higo; Satoko Aikawa; Izumi Matsuo; Ken Takumi; Atsuhiro Sakamoto; Hitoshi Ozawa
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

Review 10.  Circadian gating of neuronal functionality: a basis for iterative metaplasticity.

Authors:  Rajashekar Iyer; Tongfei A Wang; Martha U Gillette
Journal:  Front Syst Neurosci       Date:  2014-09-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.